You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 23, 2024

Prinston Inc Company Profile


✉ Email this page to a colleague

« Back to Dashboard


What is the competitive landscape for PRINSTON INC, and what generic and branded alternatives to PRINSTON INC drugs are available?

PRINSTON INC has ninety approved drugs.

There are three tentative approvals on PRINSTON INC drugs.

Summary for Prinston Inc
US Patents:0
Tradenames:80
Ingredients:79
NDAs:90

Drugs and US Patents for Prinston Inc

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Prinston Inc LISINOPRIL AND HYDROCHLOROTHIAZIDE hydrochlorothiazide; lisinopril TABLET;ORAL 076230-001 Jul 1, 2002 AB RX No No ⤷  Sign Up ⤷  Sign Up
Prinston Inc CAPTOPRIL captopril TABLET;ORAL 074477-004 Feb 13, 1996 AB RX No No ⤷  Sign Up ⤷  Sign Up
Prinston Inc QUINAPRIL HYDROCHLORIDE quinapril hydrochloride TABLET;ORAL 205823-001 Sep 15, 2016 AB RX No No ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.